Despite Mutation Acquisition in Hematopoietic Stem Cells, JMML-propagating Cells Are Not Always Restricted to This Compartment
Overview
Authors
Affiliations
Juvenile myelomonocytic leukemia (JMML) is a rare aggressive myelodysplastic/myeloproliferative neoplasm of early childhood, initiated by RAS-activating mutations. Genomic analyses have recently described JMML mutational landscape; however, the nature of JMML-propagating cells (JMML-PCs) and the clonal architecture of the disease remained until now elusive. Combining genomic (exome, RNA-seq), Colony forming assay and xenograft studies, we detect the presence of JMML-PCs that faithfully reproduce JMML features including the complex/nonlinear organization of dominant/minor clones, both at diagnosis and relapse. Further integrated analysis also reveals that although the mutations are acquired in hematopoietic stem cells, JMML-PCs are not always restricted to this compartment, highlighting the heterogeneity of the disease during the initiation steps. We show that the hematopoietic stem/progenitor cell phenotype is globally maintained in JMML despite overexpression of CD90/THY-1 in a subset of patients. This study shed new lights into the ontogeny of JMML, and the identity of JMML-PCs, and provides robust models to monitor the disease and test novel therapeutic approaches.
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia.
Fu S, Guo Y, Peng Z, Zhang D, Chang Z, Xiao Y Med Oncol. 2024; 42(1):25.
PMID: 39652257 PMC: 11628578. DOI: 10.1007/s12032-024-02549-5.
Zhan Y, Qian A, Gao J, Ma S, Deng P, Yang H Heliyon. 2024; 10(14):e34173.
PMID: 39092243 PMC: 11292241. DOI: 10.1016/j.heliyon.2024.e34173.
Arfeuille C, Vial Y, Cadenet M, Caye-Eude A, Fenneteau O, Neven Q Haematologica. 2023; 109(8):2542-2554.
PMID: 37981895 PMC: 11290538. DOI: 10.3324/haematol.2023.283917.
Sinha R, Dvorak M, Ganesan A, Kalesinskas L, Niemeyer C, Flotho C Cancers (Basel). 2023; 15(21).
PMID: 37958378 PMC: 10650722. DOI: 10.3390/cancers15215204.
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system.
Cani A, Tretti Parenzan C, Frasson C, Rampazzo E, Scarparo P, Francescato S Blood Adv. 2022; 7(8):1513-1524.
PMID: 36053787 PMC: 10130612. DOI: 10.1182/bloodadvances.2021006746.